CY1114355T1 - Aqueous solutions of strontium salts for use in the treatment of cartilage and / or bone diseases - Google Patents
Aqueous solutions of strontium salts for use in the treatment of cartilage and / or bone diseasesInfo
- Publication number
- CY1114355T1 CY1114355T1 CY20131100778T CY131100778T CY1114355T1 CY 1114355 T1 CY1114355 T1 CY 1114355T1 CY 20131100778 T CY20131100778 T CY 20131100778T CY 131100778 T CY131100778 T CY 131100778T CY 1114355 T1 CY1114355 T1 CY 1114355T1
- Authority
- CY
- Cyprus
- Prior art keywords
- strontium
- strontium salts
- cartilage
- treatment
- bone diseases
- Prior art date
Links
- 159000000008 strontium salts Chemical class 0.000 title abstract 6
- 208000020084 Bone disease Diseases 0.000 title abstract 2
- 210000000845 cartilage Anatomy 0.000 title abstract 2
- 208000015100 cartilage disease Diseases 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000007864 aqueous solution Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000001991 dicarboxylic acids Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 229910052712 strontium Inorganic materials 0.000 abstract 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 abstract 1
- XUBXWWLLZIPPHW-DFWYDOINSA-L strontium;(2s)-2-aminopentanedioate Chemical compound [Sr+2].[O-]C(=O)[C@@H](N)CCC([O-])=O XUBXWWLLZIPPHW-DFWYDOINSA-L 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Ενώσεις και φαρμακευτικές συνθέσεις για χρήση στη θεραπευτική αντιμετώπιση ή/και την προφύλαξη των παθήσεων του χόνδρου ή/και των οστών και για τις μεθόδους αντιμετώπισης των παθήσεων αυτών. Οι ενώσεις είναι άλατα του στροντίου που έχουν υδατοδιαλυτότητα από περίπου 1 g/l έως περίπου 100 g/l σε θερμοκρασία δωματίου, ειδικά τα άλατα στροντίου των αμινοξέων ή τα άλατα στροντίου των δικαρβοξυλικών οξέων. Τα παραδείγματα των νέων υδατοδιαλυτών αλάτων στροντίου είναι π.χ. το γλουταμινικό στρόντιο και το άλφα-κετογλουταρικό στρόντιο. Η παρούσα εφεύρεση αφορά επίσης σε μια βελτιωμένη μέθοδο για την παρασκευή του άλατος στροντίου του γλουταμινικού οξέος.Compounds and pharmaceutical compositions for use in the treatment and / or prophylaxis of cartilage and / or bone diseases and for the methods of treating these diseases. The compounds are strontium salts having a water solubility of from about 1 g / l to about 100 g / l at room temperature, especially the strontium salts of the amino acids or the strontium salts of the dicarboxylic acids. Examples of new water-soluble strontium salts are e.g. strontium glutamate and strontium alpha-ketoglutarate. The present invention also relates to an improved method for the preparation of the strontium salt of glutamic acid.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200300691 | 2003-05-07 | ||
| DKPA200300932 | 2003-06-20 | ||
| US52844203A | 2003-12-09 | 2003-12-09 | |
| DKPA200301820 | 2003-12-09 | ||
| EP10185891.8A EP2266585B1 (en) | 2003-05-07 | 2004-05-06 | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1114355T1 true CY1114355T1 (en) | 2016-08-31 |
Family
ID=58436486
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131100786T CY1114379T1 (en) | 2003-05-07 | 2013-09-10 | THERAPEUTIC TREATMENT OF STONE / BONE DISEASES WITH AQUATIC STRONTIUM SALTS |
| CY20131100778T CY1114355T1 (en) | 2003-05-07 | 2013-09-10 | Aqueous solutions of strontium salts for use in the treatment of cartilage and / or bone diseases |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131100786T CY1114379T1 (en) | 2003-05-07 | 2013-09-10 | THERAPEUTIC TREATMENT OF STONE / BONE DISEASES WITH AQUATIC STRONTIUM SALTS |
Country Status (1)
| Country | Link |
|---|---|
| CY (2) | CY1114379T1 (en) |
-
2013
- 2013-09-10 CY CY20131100786T patent/CY1114379T1/en unknown
- 2013-09-10 CY CY20131100778T patent/CY1114355T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1114379T1 (en) | 2016-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1105935T1 (en) | TREATMENT OF CARTILAGE AND BONE DISEASES WITH WATER-SOLUBLE STRONTIUM SALTS | |
| CY1105362T1 (en) | SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DRUGS | |
| CY1110318T1 (en) | PHAINEOXIC ACID PRODUCERS | |
| ATE446758T1 (en) | USE OF GROWTH HORMONE SECRETAGOGENES TO PROMOTE DIGESTIVE MOTILITY | |
| CY1107729T1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| TR200401142T4 (en) | Process for dissolving glucagon-like peptide compounds. | |
| CY1106003T1 (en) | N-BENZOYLUREADO-CINNAMIC ACID DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE | |
| CY1106801T1 (en) | NEW HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE AS DRUGS, PARTICULARLY AS ANTI-BACTERIALS | |
| CY1106634T1 (en) | THERAPEUTIC DERIVATIVES OF PIPERAZINE | |
| ATE421322T1 (en) | QUINOLIN-2-ONE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES | |
| EA200400022A1 (en) | CONNECTIONS AND METHODS OF TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | |
| CY1112232T1 (en) | KINOLIN PRODUCTS AS PHOSPHOSTERATION INHIBITORS | |
| EA200401114A3 (en) | SUBSTITUTED HYDROXYETHYLAMINES | |
| FI913478A0 (en) | DIAZINDERIVAT. | |
| NO20050122L (en) | Prodrug of excitation amino acids | |
| DE602004014791D1 (en) | PHENYLIC ACIDIC ACID AMID COMPOUNDS SUITABLE FOR THE TREATMENT OF PAIN | |
| PE20050822A1 (en) | FLORPHENICOL DERIVATIVES WITH BETTER SOLUBILITY IN WATER | |
| CY1112696T1 (en) | 5-HYDROXYMETHYL-OXAZOLIDIN-2-ONE PRODUCT | |
| CY1109767T1 (en) | KINAZOLIN PRODUCTS PROMOTING THE release of parathyroid hormone | |
| DE60312736D1 (en) | 1,2,4-TRIAMINOBENZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | |
| ATE460394T1 (en) | 5-ASA DERIVATIVES HAVING ANTI-INFLAMMATORY AND ANTIBIOTIC ACTION AND METHOD FOR TREATING DISEASES USING THESE DERIVATIVES | |
| CY1109085T1 (en) | NEW SALTS | |
| CY1108004T1 (en) | USE OF R-ARYLOPROPIONIC ACID FOR PRODUCTION OF MEDICINES FOR TREATMENT OF PATIENTS IN HUMANS AND ANIMALS | |
| CY1105047T1 (en) | PYRIDOPYRIMIDINONE COMPOUNDS, THEIR METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| ATE432930T1 (en) | BENZOSULFONAMIDE DERIVATIVES, THEIR PROCESS FOR PRODUCTION, AND THEIR USE FOR THE TREATMENT OF PAIN |